|
We are a national coalition of AIDS activists, many living with HIV/AIDS,working together to end the AIDS epidemic by advancing research on HIV/AIDS |
News
Member Log-in
Search
|
ATAC Pharmaceutical Report Card
With people in the U.S. with AIDS expected to live close to a normal life span, the majority of pharmaceutical companies are not developing innovative new long-term treatment options that offer improved efficacy, safety and tolerability. The ATAC Pharmaceutical Company HIV/AIDS Report Card evaluates the nine largest HIV/AIDS drug-producing pharmaceutical companies in five categories: drug development portfolio and plans, access to drugs, pricing, community relations and marketing practices. The average final grade was a C-. See below for how ATAC ranked each of the companies on the five categories, and view the additional resources for more information.
If your browser cannot display the graphic above, go here.
For the complete findings, download the Full ATAC Pharmaceutical Company Report Card on all nine companies here For the Full Report Card Background Information, click here Additional Resources:
|
